日本人群IgG4相关性疾病的全基因组关联研究
该研究对日本人群857例IgG4相关性疾病患者和2082名健康对照进行全基因组关联分析,最终纳入835例患者和1789名对照,鉴定出HLA-DRB1和FCGR2B两个易感位点,并发现HLA-DRB1肽结合槽β结构域第7位氨基酸残基关联最强,FCGR2B的rs1340976与基因表达、诊断时肿胀器官数及IgG4浓度相关。
要点
- HLA-DRB1和FCGR2B是日本人群IgG4相关性疾病的易感位点。
- HLA-DRB1肽结合槽β结构域第7位氨基酸残基关联信号最强。
- FCGR2B的rs1340976与诊断时肿胀器官数和IgG4浓度相关。
核心结论
- 鉴定出HLA-DRB1和FCGR2B两个IgG4相关性疾病易感位点,提示两者在疾病发生中可能起重要作用。
- IgG4相关性疾病与其他免疫相关疾病可能存在共同的分子机制。
研究设计与样本
- 在日本50家研究机构初筛857例IgG4相关性疾病患者和2082名来自长滨前瞻基因组队列的健康对照。
- 2008年10月27日至2014年7月22日期间入组835例患者和1789名健康对照,仅纳入符合国际诊断标准的确诊患者。
- 对HLA区域进行HLA等位基因和氨基酸残基的插补分析,并对FCGR2B区域进行精细定位。
- 分析两基因遗传变异与疾病临床表现的关联。
临床怎么用
- HLA-DRB1和FCGR2B位点可为IgG4相关性疾病的遗传易感性评估提供线索。
- FCGR2B的rs1340976与诊断时肿胀器官数和IgG4浓度相关,可能有助于病情评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: IgG4-related disease is a newly recognised immunopathological entity that includes autoimmune pancreatitis, IgG4-related sialadenitis, and IgG4-related kidney disease. To understand the genetic landscape of IgG4-related disease, we did a genome-wide association study. METHODS: We did a genome-wide association study of Japanese individuals, initially screening 857 patients with IgG4-related disease at 50 Japanese research institutions and DNA samples from 2082 healthy control participants from the Nagahama Prospective Genome Cohort for the Comprehensive Human Bioscience. From Oct 27, 2008, to July 22, 2014, we enrolled 835 patients and used data from 1789 healthy participants. Only patients with confirmed diagnosis of IgG4-related disease according to the international diagnostic criteria were included. Genotyping was done with the Infinium HumanOmni5Exome, HumanOmni2.5Exome, or HumanOmni2.5 Illumina arrays, and genomic distributions were compared between case and control samples for 958 440 single nucleotide polymorphisms. The HLA region was extensively analysed using imputation of HLA alleles and aminoacid residues. Fine mapping of the FCGR2B region was also done. Associations between clinical manifestations of disease and the genetic variations identified in these two genes were examined. FINDINGS: We identified the HLA-DRB1 (p=1·1×10-11) and FCGR2B (p=2·0×10-8) regions as susceptibility loci for IgG4-related disease. We also identified crucial aminoacid residues in the β domain of the peptide-binding groove of HLA-DRB1, in which the seventh aminoacid residue showed the strongest association signal with IgG4-related disease (p=1·7×10-14), as has been reported with other autoimmune diseases. rs1340976 in FCGR2B showed an association with increased FCGR2B expression (p=2·7×10-10) and was in weak linkage disequilibrium with rs1050501, a missense variant of FCGR2B previously associated with systemic lupus erythematosus. Furthermore, rs1340976 was associated with the number of swollen organs at diagnosis (p=0·011) and IgG4 concentration at diagnosis (p=0·035). INTERPRETATION: Two susceptibility loci for IgG4-related disease were identified. Both FCGR2B and HLA loci might have important roles in IgG4-related disease development. Common molecular mechanisms might underlie IgG4-related disease and other immune-related disorders FUNDING: The Japanese Ministry of Health, Labour, and Welfare, the Japanese Agency of Medical Research and Development, and Kyoto University Grant for Top Global University Japan Project.
引用
- Terao C, Ota M, Iwasaki T, et al. IgG4-related disease in the Japanese population: a genome-wide association study. Lancet Rheumatol. 2019. PMID: 38229354. doi:10.1016/S2665-9913(19)30006-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。